Sabby Volatility Fund Discloses 220,663 Scinai Immunotherapeutics ADSs

Ticker: SCNI · Form: SC 13G/A · Filed: 2024-01-02T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, beneficial-ownership

TL;DR

**Sabby Volatility Fund holds 220,663 Scinai Immunotherapeutics ADSs as of Dec 31, 2023.**

AI Summary

Sabby Volatility Warrant Master Fund, Ltd., a Cayman Islands-based entity, filed an amended SC 13G/A on January 2, 2024, disclosing its beneficial ownership in Scinai Immunotherapeutics Ltd. (formerly BiondVax Pharmaceuticals Ltd.). As of December 31, 2023, Sabby Volatility Warrant Master Fund, Ltd. reported shared voting power over 220,663 American Depositary Shares (ADSs) of Scinai Immunotherapeutics. This filing indicates a significant institutional investor's position in the company, which could influence stock perception and trading activity.

Why It Matters

This filing shows a notable institutional investor, Sabby Volatility Warrant Master Fund, Ltd., holds a significant stake in Scinai Immunotherapeutics, which can signal confidence or potential future trading activity to other investors.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of beneficial ownership and does not inherently indicate a high level of risk.

Analyst Insight

Investors should note that a significant institutional investor holds a stake in Scinai Immunotherapeutics, which could be a factor in future stock performance. Monitoring subsequent filings from Sabby Volatility Warrant Master Fund, Ltd. would provide further insight into their investment strategy.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the primary purpose of this SC 13G/A filing?

The primary purpose of this SC 13G/A filing is for Sabby Volatility Warrant Master Fund, Ltd. to amend its previous Schedule 13G filing and disclose its beneficial ownership of American Depositary Shares (ADSs) in Scinai Immunotherapeutics Ltd. as of December 31, 2023.

Which entity is reporting beneficial ownership in Scinai Immunotherapeutics Ltd.?

Sabby Volatility Warrant Master Fund, Ltd., organized in the Cayman Islands, is the entity reporting beneficial ownership in Scinai Immunotherapeutics Ltd.

How many shares does the reporting person have sole voting power over?

The reporting person, Sabby Volatility Warrant Master Fund, Ltd., has sole voting power over 0 shares, as indicated in item 5 of the filing.

What was the former name of Scinai Immunotherapeutics Ltd.?

The former name of Scinai Immunotherapeutics Ltd. was BiondVax Pharmaceuticals Ltd., as stated in the filing under 'Name of Issuer' and 'FORMER COMPANY'.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(c), as indicated by the 'X' next to 'Rule 13d-1(c)' in the filing.

From the Filing

0001535610-24-000015.txt : 20240102 0001535610-24-000015.hdr.sgml : 20240102 20240102165414 ACCESSION NUMBER: 0001535610-24-000015 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Scinai Immunotherapeutics Ltd. CENTRAL INDEX KEY: 0001611747 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89384 FILM NUMBER: 24503237 BUSINESS ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 BUSINESS PHONE: 972-8-9302529 MAIL ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BiondVax Pharmaceuticals Ltd. DATE OF NAME CHANGE: 20140624 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SABBY MANAGEMENT, LLC CENTRAL INDEX KEY: 0001535610 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 115 HIDDEN HILLS DR CITY: SPICEWOOD STATE: TX ZIP: 78669 BUSINESS PHONE: 646-307-4527 MAIL ADDRESS: STREET 1: 115 HIDDEN HILLS DR CITY: SPICEWOOD STATE: TX ZIP: 78669 SC 13G/A 1 scni0124.txt SCNI 13GA 1.02.24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Scinai Immunotherapeutics Ltd (previously BiondVax Pharmaceuticals Ltd.) (Name of Issuer) ADSs (Title of Class of Securities) 09073Q105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) __________ *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ? CUSIP No. 09073Q105 1. NAME OF REPORTING PERSONS Sabby Volatility Warrant Master Fund, Ltd. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 220,663 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 220,663 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 220,663 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.00 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO? CUSIP No. 09073Q105 1. NAME OF REPORTING PERSONS Sabby Management, LLC 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 220,663 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 220,663 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 220,663 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.00 12. TYPE OF REPORTI

View on Read The Filing